Tumor cell drug and radiation resistance: Does an interrelationship exist?

Author(s):  
James B. Mitchell ◽  
Angelo Russo ◽  
John A. Cook ◽  
Eli Glatstein
Author(s):  
M. Zhang ◽  
Q. Qiu ◽  
H. Min ◽  
Z. Li ◽  
D. Cardona ◽  
...  

2014 ◽  
Vol 88 (3) ◽  
pp. 677-685 ◽  
Author(s):  
Natarajan Aravindan ◽  
Sheeja Aravindan ◽  
Vijayabaskar Pandian ◽  
Faizan H. Khan ◽  
Satish Kumar Ramraj ◽  
...  

1987 ◽  
Vol 26 (01) ◽  
pp. 1-6 ◽  
Author(s):  
S. Selvaraj ◽  
M. R. Suresh ◽  
G. McLean ◽  
D. Willans ◽  
C. Turner ◽  
...  

The role of glycoconjugates in tumor cell differentiation has been well documented. We have examined the expression of the two anomers of the Thomsen-Friedenreich antigen on the surface of human, canine and murine tumor cell membranes both in vitro and in vivo. This has been accomplished through the synthesis of the disaccharide terminal residues in both a and ß configuration. Both entities were used to generate murine monoclonal antibodies which recognized the carbohydrate determinants. The determination of fine specificities of these antibodies was effected by means of cellular uptake, immunohistopathology and immunoscintigraphy. Examination of pathological specimens of human and canine tumor tissue indicated that the expressed antigen was in the β configuration. More than 89% of all human carcinomas tested expressed the antigen in the above anomeric form. The combination of synthetic antigens and monoclonal antibodies raised specifically against them provide us with invaluable tools for the study of tumor marker expression in humans and their respective animal tumor models.


Sign in / Sign up

Export Citation Format

Share Document